141 related articles for article (PubMed ID: 12853345)
1. Survivin and aven: two distinct antiapoptotic signals in acute leukemias.
Paydas S; Tanriverdi K; Yavuz S; Disel U; Sahin B; Burgut R
Ann Oncol; 2003 Jul; 14(7):1045-50. PubMed ID: 12853345
[TBL] [Abstract][Full Text] [Related]
2. [Expression of antiapoptotic gene aven in de novo acute myeloid leukemia patients and its clinical significance].
Geng SX; DU X; Weng JY; Zhong LY; Guo R; Lu ZS; Chen ZH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1424-8. PubMed ID: 20030919
[TBL] [Abstract][Full Text] [Related]
3. Expression of antiapoptotic survivin and aven genes in rat heart tissue after traumatic brain injury.
Ozisik K; Ozisik P; Yildirim E; Misirlioglu M; Tuncer S
Transplant Proc; 2006 Nov; 38(9):2784-7. PubMed ID: 17112829
[TBL] [Abstract][Full Text] [Related]
4. Disturbed expression of the anti-apoptosis gene, survivin, and EPR-1 in hematological malignancies.
Shinozawa I; Inokuchi K; Wakabayashi I; Dan K
Leuk Res; 2000 Nov; 24(11):965-70. PubMed ID: 11086180
[TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of survivin as a biomarker in neoplasms, especially in adult T-cell leukemias and acute leukemias.
Sugahara K; Uemura A; Harasawa H; Nagai H; Hirakata Y; Tomonaga M; Murata K; Sohda H; Nakagoe T; Shibasaki S; Yamada Y; Kamihira S
Int J Hematol; 2004 Jul; 80(1):52-8. PubMed ID: 15293568
[TBL] [Abstract][Full Text] [Related]
6. Quantitatively determined survivin expression levels are of prognostic value in human gliomas.
Chakravarti A; Noll E; Black PM; Finkelstein DF; Finkelstein DM; Dyson NJ; Loeffler JS
J Clin Oncol; 2002 Feb; 20(4):1063-8. PubMed ID: 11844831
[TBL] [Abstract][Full Text] [Related]
7. Expression of MDR1 gene in acute leukemia cells: association with CD7+ acute myeloblastic leukemia/acute lymphoblastic leukemia.
Miwa H; Kita K; Nishii K; Morita N; Takakura N; Ohishi K; Mahmud N; Kageyama S; Fukumoto M; Shirakawa S
Blood; 1993 Dec; 82(11):3445-51. PubMed ID: 7694687
[TBL] [Abstract][Full Text] [Related]
8. Expression of genes related to multiple drug resistance and apoptosis in acute leukemia: response to induction chemotherapy.
Chauhan PS; Bhushan B; Singh LC; Mishra AK; Saluja S; Mittal V; Gupta DK; Kapur S
Exp Mol Pathol; 2012 Feb; 92(1):44-9. PubMed ID: 22037714
[TBL] [Abstract][Full Text] [Related]
9. Expressions of cyclin E2 and survivin in acute leukemia and their correlation.
Wang Y; Xu SR; Lin FR; Guo XN; Ren JH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):337-42. PubMed ID: 16638210
[TBL] [Abstract][Full Text] [Related]
10. [Expression of antigen CD40 and survivin gene and their clinical implications in acute myeloid leukemia].
Zhu FB; Wang SY; Zhang YW
Zhonghua Nei Ke Za Zhi; 2004 Oct; 43(10):769-72. PubMed ID: 15631832
[TBL] [Abstract][Full Text] [Related]
11. Expression of antiapoptotic proteins livin and survivin in pediatric AML patients, as prognostic markers.
Zareifar S; Ghorbani S; Monabbati A; Bordbar MR; Zekavat OR; Abdolkarimi B; Haghpanah S
Pediatr Hematol Oncol; 2018 May; 35(4):250-256. PubMed ID: 30588872
[TBL] [Abstract][Full Text] [Related]
12. [Clinical study on prognosis of acute leukemia subtypes Ly + AML and My + ALL].
Liu B; Li R; Wu HJ; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):421-4. PubMed ID: 17493361
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of the anti-apoptotic protein AVEN contributes to increased malignancy in hematopoietic neoplasms.
Eißmann M; Melzer IM; Fernández SB; Michel G; Hrabě de Angelis M; Hoefler G; Finkenwirth P; Jauch A; Schoell B; Grez M; Schmidt M; Bartholomae CC; Newrzela S; Haetscher N; Rieger MA; Zachskorn C; Mittelbronn M; Zörnig M
Oncogene; 2013 May; 32(20):2586-91. PubMed ID: 22751129
[TBL] [Abstract][Full Text] [Related]
14. Adult and childhood acute lymphoblastic leukemia: clinico-biological differences based on CD34 antigen expression.
Cascavilla N; Musto P; D'Arena G; Ladogana S; Matera R; Carotenuto M
Haematologica; 1997; 82(1):31-7. PubMed ID: 9107079
[TBL] [Abstract][Full Text] [Related]
15. [Expression of survivin, Fas, bcl-2 and bax in bone marrow cells from acute myeloid leukemia patients and its clinical significance].
Lin FR; Wang Y; Wang RQ; Du XY; Guo XN; Ren JH; Guo XL; Yao L; Yao EG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Jun; 11(3):259-62. PubMed ID: 12844408
[TBL] [Abstract][Full Text] [Related]
16. AC133 antigen as a prognostic factor in acute leukemia.
Lee ST; Jang JH; Min YH; Hahn JS; Ko YW
Leuk Res; 2001 Sep; 25(9):757-67. PubMed ID: 11489469
[TBL] [Abstract][Full Text] [Related]
17. Expression and prognostic significance of survivin in de novo acute myeloid leukaemia.
Adida C; Recher C; Raffoux E; Daniel MT; Taksin AL; Rousselot P; Sigaux F; Degos L; Altieri DC; Dombret H
Br J Haematol; 2000 Oct; 111(1):196-203. PubMed ID: 11091201
[TBL] [Abstract][Full Text] [Related]
18. Molecular detection of survivin expression, antiapoptotic gene, and other prognostic markers, how they are correlated and how it could be of prognostic value in chronic myeloid leukemia patient.
Zhara M; Mourad H; Farouk G; Elbatch M; Ezzat S; Sami W
Egypt J Immunol; 2007; 14(2):51-62. PubMed ID: 20306657
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the expression level of Survivin gene in different groups of B-cell acute lymphoblastic leukemia patients of Iran.
Mohammadi M; Amirmahani F; Goharrizi KJ; Pakzad R; Dolat H
Mol Biol Rep; 2019 Jun; 46(3):2679-2684. PubMed ID: 31037549
[TBL] [Abstract][Full Text] [Related]
20. Survivin and its prognostic significance in pediatric acute B-cell precursor lymphoblastic leukemia.
Troeger A; Siepermann M; Escherich G; Meisel R; Willers R; Gudowius S; Moritz T; Laws HJ; Hanenberg H; Goebel U; Janka-Schaub GE; Mahotka C; Dilloo D
Haematologica; 2007 Aug; 92(8):1043-50. PubMed ID: 17640858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
